Mycondro™

MyCondro™: The Chondroitin by Fermentation, Disrupting the Chondroitin Sulfate Market MyCondro™ is the world's non-animal chondroitin by fermentation, offering an ethical, effective, and science-backed joint health solution. The name reflects what sets it apart: “My” highlights its biomimetic nature, closely resembling the chondroitin sulfate naturally found in the human body, while “Condro” connects directly to the core molecule—chondroitin sulfate—crafted without the use of animal sources. Created through precision microbial fermentation, MyCondro™ delivers consistent purity, proven efficacy, and superior bioavailability. It addresses long-standing concerns associated with animal-derived chondroitin sulfate, including heterogeneity, safety, and traceability, which have challenged the credibility and performance of conventional sources. This innovation comes at a time when joint health is no longer just for older adults. A younger, more active, and sustainability-minded audience demands clean-label ingredients with real, measurable benefits. MyCondro™ meets this demand head-on with a convenient and clinically validated dose of 600 mg/day) ensuring performance without compromise. Developed by Gnosis by Lesaffre, MyCondro™ is more than a bioactive—it's a commitment to advancing joint health through biotechnology and corporate responsibility. By leveraging fermentation, Gnosis delivers a solution that is not only effective and safe, but also aligned with environmental values. MyCondro™ paves the way for a long-term, scalable, and planet-friendly answer to joint support—ideal for supplement brands and manufacturers looking to stand out in a competitive market.